Hessov I, Allen J, Arendt K, Gravholt L
Acta Chir Scand. 1977;143(3):151-4.
In hospitals where 5% glucose is the solution most often infused, the incidence of thrombophlebitis has been found to be 27-43%. In an attempt to reduce this incidence, the following principles for the administration of intravenous solutions were established in a surgical department: (1) No cannula to be placed in the same vein for continuous infusion for a period of more than 24 hours, (2) All sugar solutions to be neutralized with a phosphate buffer. (3) The thinnest possible cannulas are to be used. (4) Vein irritant solutions to be given as quickly as permissible. (5) Veins with the largest diameter to be used first. These principles were adhered to for a period of 4 months. The daily infusion period was 11-14 hours. Of 196 patients who received infusions for a total of 529 days, infusion thrombophlebitis developed in 6.1% (3-10%). 113 of these patients received (among other solutions) 1000-2000 ml 10% invertose per day. This solution was given for an average of 4 days. 9.7% (5-17%) of the patients in this group developed infusion thrombophlebitis. No patient had more than one episode of infusion thrombophlebitis.
在最常输注5%葡萄糖溶液的医院中,已发现血栓性静脉炎的发生率为27%至43%。为降低这一发生率,某外科制定了以下静脉输液管理原则:(1)同一静脉连续输液时间不得超过24小时;(2)所有糖溶液均用磷酸盐缓冲液中和;(3)尽可能使用最细的套管针;(4)静脉刺激性溶液应尽快输注;(5)优先使用直径最大的静脉。这些原则坚持了4个月。每日输液时间为11至14小时。在总共接受529天输液的196例患者中,输液性血栓性静脉炎的发生率为6.1%(3%至10%)。其中113例患者(除其他溶液外)每天接受1000至2000毫升10%转化糖溶液。该溶液平均输注4天。该组患者中有9.7%(5%至17%)发生输液性血栓性静脉炎。没有患者发生超过一次输液性血栓性静脉炎。